What Is CME Fair Value?
CME Group Inc. (CME) fair value estimate using multiple valuation models, updated daily.
As of October 31, 2026, CME Group Inc. (CME) has a composite fair value estimate of $266.02 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $303.14, suggesting the stock is fair value by 12.2%.
Data as of October 31, 2026 (today)
Composite Fair Value
Fair Value4 of 4 models$266.02
vs. current price of $303.14(-12.2%)
How Is CME Fair Value Calculated?
Four independent models estimate what CME is worth. Each uses different inputs and assumptions. The composite blends them by weight.
CME Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$362.25
+19.5%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$332.39
+9.7%Fair Value
Inputs used
CME Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$143.99
-52.5%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$124.00
-59.1%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $303.14 is 19.5% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $3.32B | $3.13B |
| Year 2 | $3.61B | $3.21B |
| Year 3 | $3.92B | $3.30B |
| Year 4 | $4.26B | $3.39B |
| Year 5 | $4.63B | $3.47B |
| Year 6 | $5.03B | $3.57B |
| Year 7 | $5.47B | $3.66B |
| Year 8 | $5.95B | $3.76B |
| Year 9 | $6.47B | $3.86B |
| Year 10 | $7.03B | $3.96B |
| Terminal Value | $211.00B | $118.77B |
What Are CME's Key Financial Metrics?
Earnings & Growth
Current Price
$303.14
EPS (TTM)
$12.20
Forward P/E
22.9
Profit Margin
63.5%
Cash & Balance Sheet
Free Cash Flow
3.1B
EBITDA
4.9B
Book Value
$74.31
Total Debt
3.9B
What Do Analysts Say About CME?
Low
$227.00
Average
$317.06
High
$367.00
Upside
+4.6%
CME Fair Value FAQ
What is the fair value of CME?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CME's estimated fair value is $266.02. The stock is currently trading at $303.14, which makes it fair value by our analysis.
How is CME's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is CME overvalued or undervalued?
Based on our analysis, CME is fair value. The current price of $303.14 is 12.2% above our estimated fair value of $266.02.
What do Wall Street analysts say about CME?
16 analysts cover CME Group Inc. with a consensus rating of "Buy." The average price target is $317.06, ranging from $227.00 to $367.00. This implies 4.6% upside from the current price.